Advertisement

Ads Placeholder
Loading...

Repligen Corporation

RGEN•NASDAQ
Healthcare
Medical - Instruments & Supplies
$116.00
$-2.32(-1.97%)
U.S. Market is Open • 10:29

Repligen Corporation (RGEN) Stock Overview

Explore Repligen Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.6B
P/E Ratio136.15
EPS (TTM)$0.86
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$142.83
3 Months$108.26
1 Year Target$118.54

RGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Repligen Corporation (RGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $118.54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 136.15 and a market capitalization of 6.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.46%
5-Day Change
3.94%
1-Month Change
-4.29%
3-Month Change
-28.34%
6-Month Change
-20.81%
Year-to-Date (YTD) Change
-28.34%
1-Year Change
-3.22%
3-Year Change
-27.94%
5-Year Change
-41.23%
All-Time (Max) Change
946.93%

Contact Information

https://www.repligen.com
781 250 0111
Building 1, Waltham, MA, 02453

Company Facts

17,780 Employees
IPO DateApr 29, 1986
CountryUS
Actively Trading

Frequently Asked Questions